Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Boyer

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2019
Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndromeFlorence Wong, Thomas D Boyer, Arun J Sanyal, et al.
The American Journal of Gastroenterology|May 23, 2008
Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver functionMichael R Lucey, Jason T Connor, Thomas D Boyer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2016
Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response SyndromeFlorence Wong, Stephen Chris Pappas, Thomas D Boyer, et al.
Journal of Hepatology|December 21, 2010
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamicsThomas D Boyer, Arun J Sanyal, Guadalupe Garcia-Tsao, et al.
World Journal of Gastrointestinal Endoscopy|August 24, 2011
Endoscopic ultrasound with biopsy of omental mass for cholangiocarcinoma diagnosis in cirrhosisNathaniel S Rial, Kevin B Gilchrist, Jeff T Henderson, et al.
Gastroenterology|May 16, 2006
Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trialJ Michael Henderson, Thomas D Boyer, Michael H Kutner, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Constitutional telomerase mutations are genetic risk factors for cirrhosisRodrigo T Calado, Jennifer Brudno, Paulomi Mehta, et al.
Gastroenterology|February 21, 2016
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1Thomas D Boyer, Arun J Sanyal, Florence Wong, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2011
Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1Thomas D Boyer, Arun J Sanyal, Guadalupe Garcia-Tsao, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Screening in liver disease: report of an AASLD clinical workshopPaul C Adams, Michael J Arthur, Thomas D Boyer, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2019
Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndromeFlorence Wong, Thomas D Boyer, Arun J Sanyal, et al.
The American Journal of Gastroenterology|May 23, 2008
Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver functionMichael R Lucey, Jason T Connor, Thomas D Boyer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2016
Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response SyndromeFlorence Wong, Stephen Chris Pappas, Thomas D Boyer, et al.
Journal of Hepatology|December 21, 2010
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamicsThomas D Boyer, Arun J Sanyal, Guadalupe Garcia-Tsao, et al.
World Journal of Gastrointestinal Endoscopy|August 24, 2011
Endoscopic ultrasound with biopsy of omental mass for cholangiocarcinoma diagnosis in cirrhosisNathaniel S Rial, Kevin B Gilchrist, Jeff T Henderson, et al.
Gastroenterology|May 16, 2006
Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trialJ Michael Henderson, Thomas D Boyer, Michael H Kutner, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Constitutional telomerase mutations are genetic risk factors for cirrhosisRodrigo T Calado, Jennifer Brudno, Paulomi Mehta, et al.
Gastroenterology|February 21, 2016
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1Thomas D Boyer, Arun J Sanyal, Florence Wong, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2011
Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1Thomas D Boyer, Arun J Sanyal, Guadalupe Garcia-Tsao, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Screening in liver disease: report of an AASLD clinical workshopPaul C Adams, Michael J Arthur, Thomas D Boyer, et al.
Pageof 5